In the intricate world of clinical trials, having a seasoned medical consultant by your side can make all the difference. Since 2021, JDH Clinical Trial Consulting offers a comprehensive suite of medical consulting services designed to streamline your clinical trial process, enhance safety, and ensure regulatory compliance, propelling your research to new heights.
JDH Clinical Trial Consulting understands the complexity and challenges of navigating clinical trials in today's rapidly evolving healthcare landscape. Our mission is to guide biotech and pharmaceutical companies through the intricate process of clinical trial design, execution, and management with unparalleled expertise and personalized support.
With over 13 years of hands-on experience in clinical trial oversight, Dr. Hurt brings a wealth of knowledge from conducting and advising on trials across a variety of therapeutic areas. His deep understanding of the regulatory landscape and patient safety protocols ensures your trial is not only compliant but also poised for success.
JDH Clinical Trial Consulting specializes in translating complex scientific concepts into actionable strategies. My approach is tailored to your trial's specific needs, focusing on innovative solutions to optimize trial design, enhance patient recruitment, and streamline operations.
JDH Clinical Trial Consulting recognizes the importance of teamwork in clinical trials, and will work closely with your team, offering guidance, training, and support to ensure all members are aligned and equipped to meet the trial's objectives.
Navigating the potential pitfalls of clinical trials can be daunting. We employ a proactive approach to identify and address risks early on, ensuring your trial remains on track and within regulatory guidelines.
Whether your trial is local or international, my experience in global clinical research provides the insights necessary to navigate different regulatory environments and cultural considerations, ensuring a smooth trial process across borders.
Neuroendocrine tumors of the gut (GEP-NETs)
Prostate cancer
Breast Cancer
Cervical Cancer (and other HPV Related cancers)
Melanoma
Ovarian cancer
Lung Cancer
Colorectal Cancer
Hepatocellular Carcinoma
Graft Vs Host Disease
CLL
Parkinson's Disease
Cerebral Palsy
Friedreich's Ataxia
Alport Syndrome
IgA Nephropathy
CKD Associated With Type 1 Diabetes
Focal Segmental Glomerulosclerosis
Autosomal Dominant Polycystic Kidney
Small molecules
Biologics
Radioligand therapy
Immunotherapy
Immuno-oncology
ADCs
CAR-T
Mon | 09:00 am – 05:00 pm | |
Tue | 09:00 am – 05:00 pm | |
Wed | 09:00 am – 05:00 pm | |
Thu | 09:00 am – 05:00 pm | |
Fri | 09:00 am – 05:00 pm | |
Sat | Closed | |
Sun | Closed |
Jason D. Hurt, MD, MBA, is a distinguished pharmaceutical physician leader with a robust track record in the drug development process. His career spans significant roles, including Chief Medical Officer at OranoMed, where he led medical and clinical development strategies, and Senior Medical Director at Reata Pharmaceuticals, contributing to the development of innovative treatments. Jason's expertise extends to orchestrating clinical trials, managing cross-functional teams, and ensuring regulatory compliance. His leadership style combines coaching and mentoring, emphasizing high performance and strategic insight. Jason's academic and professional credentials, complemented by his MBA from Xavier University and Doctor of Medicine from Texas Tech University, underscore his commitment to advancing medical research and development.
Copyright © 2024 JDH Clinical Trial Consulting - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.